title: Mesenchymal stem cells control alloreactive CD8(+) CD28(-) T cells.
abstract: CD28/B7 co-stimulation blockade with belatacept prevents alloreactivity in kidney transplant patients. However, cells lacking CD28 are not susceptible to belatacept treatment. As CD8(+) CD28(-) T-cells have cytotoxic and pathogenic properties, we investigated whether mesenchymal stem cells (MSC) are effective in controlling these cells. In mixed lymphocyte reactions (MLR), MSC and belatacept inhibited peripheral blood mononuclear cell (PBMC) proliferation in a dose-dependent manner. MSC at MSC/effector cell ratios of 1:160 and 1:2·5 reduced proliferation by 38·8 and 92·2%, respectively. Belatacept concentrations of 0·1 μg/ml and 10 μg/ml suppressed proliferation by 20·7 and 80·6%, respectively. Both treatments in combination did not inhibit each other's function. Allostimulated CD8(+) CD28(-) T cells were able to proliferate and expressed the cytolytic and cytotoxic effector molecules granzyme B, interferon (IFN)-γ and tumour necrosis factor (TNF)-α. While belatacept did not affect the proliferation of CD8(+) CD28(-) T cells, MSC reduced the percentage of CD28(-) T cells in the proliferating CD8(+) T cell fraction by 45·9% (P = 0·009). CD8(+) CD28(-) T cells as effector cells in MLR in the presence of CD4(+) T cell help gained CD28 expression, an effect independent of MSC. In contrast, allostimulated CD28(+) T cells did not lose CD28 expression in MLR-MSC co-culture, suggesting that MSC control pre-existing CD28(-) T cells and not newly induced CD28(-) T cells. In conclusion, alloreactive CD8(+) CD28(-) T cells that remain unaffected by belatacept treatment are inhibited by MSC. This study indicates the potential of an MSC-belatacept combination therapy to control alloreactivity.
authors.affiliation: Department of Internal Medicine, Section Nephrology and Transplantation, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
authors.forename: A U
authors.initials: AU
authors.lastname: Engela
authors.forename: C C
authors.initials: CC
authors.lastname: Baan
authors.forename: N H R
authors.initials: NH
authors.lastname: Litjens
authors.forename: M
authors.initials: M
authors.lastname: Franquesa
authors.forename: M G H
authors.initials: MG
authors.lastname: Betjes
authors.forename: W
authors.initials: W
authors.lastname: Weimar
authors.forename: M J
authors.initials: MJ
authors.lastname: Hoogduijn
mesh_terms: D000069594:Abatacept; D017209:Apoptosis; D018106:CD28 Antigens / Q000378:metabolism*; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D049109:Cell Proliferation; D002478:Cells, Cultured; D053804:Granzymes / Q000096:biosynthesis; D006801:Humans; D018796:Immunoconjugates / Q000494:pharmacology*; D007371:Interferon-gamma / Q000096:biosynthesis; D007963:Leukocytes, Mononuclear / Q000166:cytology / Q000187:drug effects / Q000276:immunology*; D008213:Lymphocyte Activation / Q000276:immunology; D007959:Lymphocyte Culture Test, Mixed; D059630:Mesenchymal Stem Cells / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis
chemical_list: D018106:CD28 Antigens; D018796:Immunoconjugates; D014409:Tumor Necrosis Factor-alpha; D000069594:Abatacept; D007371:Interferon-gamma; D053804:Granzymes
keywords: CD8 T cells; co-stimulation/co-stimulatory molecules; immune regulation; stem cells
references.citation: Clin J Am Soc Nephrol. 2011 Feb;6(2):412-22
references.pmid: 20930086
references.citation: J Biol Chem. 2001 Jan 26;276(4):2565-70
references.pmid: 11069899
references.citation: J Exp Med. 2000 Oct 2;192(7):1027-34
references.pmid: 11015443
references.citation: Curr Opin Organ Transplant. 2012 Feb;17(1):55-62
references.pmid: 22186092
references.citation: Cell Immunol. 2010;262(2):75-9
references.pmid: 20219185
references.citation: Eur J Immunol. 2005 May;35(5):1482-90
references.pmid: 15827960
references.citation: Am J Transplant. 2012 Jan;12(1):210-7
references.pmid: 21992533
references.citation: Blood. 2003 May 1;101(9):3543-9
references.pmid: 12506015
references.citation: Nat Immunol. 2001 Mar;2(3):261-8
references.pmid: 11224527
references.citation: J Clin Immunol. 2008 Sep;28(5):464-72
references.pmid: 18704663
references.citation: Transplantation. 2001 Jun 15;71(11 Suppl):SS42-51
references.pmid: 11583488
references.citation: Transpl Int. 2012 Feb;25(2):139-50
references.pmid: 22151353
references.citation: Immunol Rev. 2009 May;229(1):307-21
references.pmid: 19426230
references.citation: J Immunol. 2007 Oct 1;179(7):4323-34
references.pmid: 17878327
references.citation: Clin Exp Immunol. 2013 Aug;173(2):343-54
references.pmid: 23607314
references.citation: J Clin Immunol. 2011 Aug;31(4):588-95
references.pmid: 21487894
references.citation: Immunology. 2011 Sep;134(1):17-32
references.pmid: 21711350
references.citation: Immunology. 1996 Aug;88(4):501-7
references.pmid: 8881749
references.citation: Int Immunol. 1998 Jun;10(6):775-83
references.pmid: 9678758
references.citation: Clin Exp Immunol. 2013 Dec;174(3):424-32
references.pmid: 23962178
references.citation: J Virol. 1996 Mar;70(3):2022-6
references.pmid: 8627730
references.citation: J Immunol. 2008 Aug 15;181(4):2285-91
references.pmid: 18684917
references.citation: Clin Immunol Immunopathol. 1994 Apr;71(1):8-13
references.pmid: 8137561
references.citation: Am J Transplant. 2013 Jan;13 Suppl 1:11-46
references.pmid: 23237695
references.citation: Clin Immunol. 2002 Nov;105(2):117-25
references.pmid: 12482386
references.citation: Stem Cells Dev. 2007 Aug;16(4):597-604
references.pmid: 17784833
references.citation: J Exp Med. 2001 Apr 2;193(7):839-46
references.pmid: 11283156
references.citation: Transplant Proc. 2009 Oct;41(8):3347-52
references.pmid: 19857747
references.citation: Immun Ageing. 2012 Sep 12;9(1):19
references.pmid: 22971545
references.citation: Am J Transplant. 2010 Mar;10(3):547-57
references.pmid: 20415898
references.citation: Transplantation. 2009 Mar 27;87(6):896-906
references.pmid: 19300194
references.citation: Immunity. 2008 Dec 19;29(6):848-62
references.pmid: 19100699
references.citation: J Rheumatol. 1999 Jul;26(7):1452-7
references.pmid: 10405929
references.citation: J Immunol. 2006 Dec 1;177(11):7802-10
references.pmid: 17114451
references.citation: Am J Hum Genet. 1993 Apr;52(4):661-7
references.pmid: 8460632
references.citation: J Biol Chem. 2009 Aug 14;284(33):22022-22028
references.pmid: 19531476
references.citation: Am J Transplant. 2013 Jan;13 Suppl 1:73-102
references.pmid: 23237697
references.citation: Eur J Immunol. 2008 Apr;38(4):995-1000
references.pmid: 18383036
references.citation: Science. 2008 Oct 10;322(5899):271-5
references.pmid: 18845758
references.citation: BMC Immunol. 2001;2:10
references.pmid: 11696237
references.citation: Lancet. 2008 May 10;371(9624):1579-86
references.pmid: 18468541
references.citation: Hum Immunol. 2004 Nov;65(11):1297-306
references.pmid: 15556680
references.citation: Stem Cells Transl Med. 2013 Feb;2(2):107-11
references.pmid: 23349326
references.citation: Ann N Y Acad Sci. 2012 Aug;1266:107-17
references.pmid: 22901262
references.citation: Transplantation. 2012 Jul 15;94(1):63-9
references.pmid: 22691956
references.citation: Exp Hematol. 2002 Jan;30(1):42-8
references.pmid: 11823036
references.citation: Transpl Int. 2013 Jun;26(6):651-8
references.pmid: 23682671
references.citation: J Clin Invest. 2013 Feb;123(2):580-93
references.pmid: 23281398
references.citation: Arthritis Rheum. 1997 Feb;40(2):237-48
references.pmid: 9041935
references.citation: Am J Transplant. 2010 Mar;10(3):535-46
references.pmid: 20415897
references.citation: Am J Transplant. 2012 Sep;12(9):2313-21
references.pmid: 22759373
references.citation: Arthritis Res. 2002;4(1):71-6
references.pmid: 11879540
references.citation: J Exp Med. 1992 Nov 1;176(5):1387-98
references.pmid: 1357073
references.citation: Mediators Inflamm. 2005 Aug 14;2005(3):160-6
references.pmid: 16106102
references.citation: Hepatobiliary Pancreat Dis Int. 2009 Jun;8(3):241-6
references.pmid: 19502162
references.citation: J Immunol. 1993 Feb 15;150(4):1147-59
references.pmid: 8381831
references.citation: Nat Med. 1999 Dec;5(12):1365-9
references.pmid: 10581077
references.citation: Transplantation. 2003 Feb 15;75(3):389-97
references.pmid: 12589164
references.citation: J Immunol. 1997 Feb 1;158(3):1482-9
references.pmid: 9013995
references.citation: J Biol Chem. 1998 Apr 3;273(14):8119-29
references.pmid: 9525915
references.citation: Cancer Immunol Immunother. 2003 Oct;52(10):599-607
references.pmid: 12827303
references.citation: J Immunol. 1996 May 15;156(10):3587-90
references.pmid: 8621891
references.citation: Immunol Rev. 2005 Jun;205:158-69
references.pmid: 15882352
references.citation: AIDS. 1994 Apr;8(4):431-41
references.pmid: 8011246
references.citation: Transplantation. 2008 Nov 15;86(9):1283-91
references.pmid: 19005411
references.citation: J Immunol. 2007 Jun 15;178(12):7710-9
references.pmid: 17548608
references.citation: Clin Immunol. 2000 Sep;96(3):230-5
references.pmid: 10964541
references.citation: Clin Exp Immunol. 2011 Oct;166(1):94-102
references.pmid: 21910726